2m 2m 2m 2m 2m 2m 2m
Halberd (HALB)
OTC
$0.0009$0.00 (0.00%)
Price as of Jul 30, 2026- $636,573.00Market Cap
- -63.27%1-Year Change
- BiotechnologyIndustry
Halberd (HALB)
$0.0009$0.00 (0.00%)
Key Performance
More- Earnings Score: N/A
- Momentum Score: 33
- True Yield: N/A
- Financial Health Score: N/A
Latest Research & News
No data found
Peers
Statistics
MoreDay Range
$0.0008
$0.001
$0.0009
1-Year Range
$0.0007
$0.003
$0.0009
Latest Close$0.0009
Change
$0.00 (0.00%)
Volume25,310
Market Cap$636,573.00
Shares Outstanding707.3M
P/E (TTM)-1.50
Diluted EPS (TTM)-$0.0006
Enterprise Value$985,345.00
Information as of 07/30/2026
Company Profile
HALBERD CORP
https://halberdcorporation.com$636,573.00
Market Cap
-$297,172.00
Net Income
Sector: Healthcare
Industry: Biotechnology
PO Box 25, Jackson Center, PA, United States, 16133
814 786 8849Halberd Corporation, a biotech company, develops treatments for neurodegenerative diseases. It offers treatments for post traumatic stress disorder/chronic traumatic encephalopathy, Alzheimer's and Parkinson's disease, cancer, blood-borne, and cerebrospinal fluid related diseases. The company was incorporated in 2009 and is based in Jackson Center, Pennsylvania.
Key Executives
- John S. Borza
- Heidi H. Carl
- Patricio F. Reyes FAAN
- Mitchell S. Felder
- William A. Hartman
Current Ownership Distribution
- Other515.9M (100.00%)
- Institutions0 (0.00%)
- Mutual Funds0 (0.00%)
- Insiders0 (0.00%)